Table 1 Demographics of study population

Sex (Male: Female)

84: 23

12: 1

72: 22

0.19

Age (years)^a

55.1 ± 8.8

59 ± 5.1

54.6 ± 9.1

0.09

BMI, before LT (kg/m²) ^a

24.2 ± 3.4

26.4 ± 3.1

23.8 ± 3.4

0.01

BMI, 1 year after LT (kg/m²)^a

22.9 ± 3.3

26.3 ± 3.2

22.4 ± 3.1

 < 0.001

BMI, 2 years after LT (kg/m²)^a

23 ± 3.3

26.4 ± 3.1

22.5 ± 3

 < 0.001

LDLT

80 (74.8)

9

71

0.62

Underlying malignancy

74 (69.2)

10

64

0.52

Etiology

0.17

 Hepatitis B

71 (66.4)

11

60

 Hepatitis C

14 (13.1)

0

14

 Alcohol

15 (14)

2

13

 Autoimmune hepatitis

2 (1.9)

0

2

 NBNC

1 (0.9)

0

1

 Wilson disease

2 (1.9)

0

2

 Primary biliary cirrhosis

2 (1.9)

0

2

SMI, before LT (cm²/m²)^a

37.8 ± 8.5

47 ± 7.2

36.6 ± 7.9

 < 0.001

SMI, 1 year after LT (cm²/m²)^a

36 ± 8.4

45.1 ± 5.6

34.8 ± 7.9

 < 0.001

SMI, 2 years after LT (cm²/m²)^a

36.2 ± 7.5

45.7 ± 5.1

34.9 ± 6.8

 < 0.001

PTDM

10 (9.3)

0

10

0.22

HTN after LT

4 (3.7)

0

4

0.45

Renal failure

9 (8.4)

1

8

0.58

Chronic rejection

1 (0.9)

0

1

0.71

MELD

17.5 ± 5.2

14.7 ± 3.1

17.9 ± 5.3

0.04